Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours

•Report on an extensive QA-programme for an SBRT trial for central lung tumours.•Small variations in OAR delineation potentially leads to large OAR over-dosage.•Extensive QA decreases variability in OAR delineation and treatment planning.•QA of OAR delineations may lead to a more coherent interpreta...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Radiotherapy and oncology 2022-06, Vol.171, p.53-61
Hauptverfasser:	Hoffmann, L., Persson, G.F., Nygård, L., Nielsen, T.B., Borrisova, S., Gaard-Petersen, F., Josipovic, M., Khalil, A.A., Kjeldsen, R., Knap, M.M., Kristiansen, C., Møller, D.S., Ottosson, W., Sand, H., Thing, R., Pøhl, M., Schytte, T.
Format:	Artikel
Sprache:	eng
Schlagworte:	Central tumours Humans Lung Neoplasms - radiotherapy Lung Neoplasms - surgery Lung tumours Organs at Risk Quality assurance Radiosurgery - adverse effects Radiosurgery - methods Radiotherapy Dosage Radiotherapy Planning, Computer-Assisted - methods Radiotherapy, Intensity-Modulated - methods Retrospective Studies Stereotactic body radiotherapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!